[
  {
    "objectID": "publications.html",
    "href": "publications.html",
    "title": "Publications",
    "section": "",
    "text": "As bioinformatics co-author contributing computational analysis expertise\n\n\n\nJournal: iScience (2025) | DOI: 10.1016/j.isci.2025.113842\nAuthors: Kaufmann U, Wang J, Callow M, Fortin J, Myrta S, Nickles D, et al.\n\n\nâ–¸ CRISPR Screen Analysis: Processed ~160,000 sgRNAs using crisprVerse (screenCounter), TMM normalization on non-essential genes, limma-voom with robust empirical Bayes\nâ–¸ RNA-seq (Bulk): HTSeqGenie pipeline, GSNAP alignment (GRCh38), differential expression (edgeR, voom/limma), pathway enrichment (MSigDB Hallmark)\nâ–¸ ChIP-seq Integration: Public data analysis (GEO: GSE102616), BWA alignment, promoter enrichment (ZFX binding sites in 4 cancer cell lines)\nâ–¸ Clinical Data Analysis: TCGA integration, Cox proportional hazards models for survival, correlation analysis (ZFX expression vs patient outcomes)\nâ–¸ Visualization: Volcano plots, heatmaps, Kaplan-Meier curves, scatter plots\nKey Findings: Identified ZFX as biomarker for immunotherapy response; ZFX regulates apoptosis pathway genes including CASP3\nData: GEO accessions GSE276964 (in vitro), GSE276965 (in vivo)\n\n\n\n\n\nJournal: Cancer Immunology Research (2024) | DOI: 10.1158/2326-6066.CIR-23-0800\nAuthors: Besla R, Penuel E, Rosario GD, Cosino E, Myrta S, Polson AG, et al.\n\n\nâ–¸ RNA-seq (Sorted NK Cells): Smart-Seq V4 library prep (2ng input), HTSeqGenie processing, edgeR (logCPM), voom/limma differential expression (baseline vs 24h TDB)\nâ–¸ Gene Set Enrichment: fgsea with MSigDB collections (c2, c5, c7), pathway visualization (IFN, TNF, interleukin pathways)\nâ–¸ Cytokine Analysis: Luminex multiplex data integration (Human CD8+ T-cell 17+plex panel)\nâ–¸ Flow Cytometry Data: FlowJo analysis support, gating strategy optimization\nâ–¸ Visualization: Heat maps, bar graphs with multiple comparisons, pathway network diagrams\nKey Findings: TDB treatment activates NK cells via IL2/IL10 axis; enhanced ADCC observed in vitro and in vivo\nData: EGA accession EGAS00001006914\n\n\n\n\n\nJournal: bioRxiv (2023) | DOI: 10.1101/2023.07.24.550274\nAuthors: Laing S, Kruspig B, Shaw R, Officer-Jones L, Edwards S, McKinven D, Myrta S, et al.\n\n\nâ–¸ Bulk RNA-seq: Multiple timepoints (8w, 12w, endpoint), Metacore GeneGO pathway analysis, differential expression\nâ–¸ Single-Cell RNA-seq: 10X Genomics Chromium (40,000 cells/sample), 22 clusters identified using ImmGen databrowser, PANTHER overrepresentation analysis\nâ–¸ Pathway Enrichment: EGFR/ERBB signaling (33.5x enrichment, FDR 1.06e-2), immune evasion pathways\nâ–¸ Whole Exome Sequencing: COSMIC signature analysis (APOBEC mutagenesis signatures)\nâ–¸ Visualization: UMAPs, violin plots, correlation plots (AREG vs p-ERBB2), heatmaps\nKey Findings: ERBB ligand upregulation (AREG, HBEGF) mediates immune escape post-Î±PD-1 treatment; Afatinib restores immune infiltration\n\n\n\n\n\nJournal: Clinical Cancer Research (2021) | DOI: 10.1158/1078-0432.CCR-20-1835\nAuthors: Daemen A, Cooper JE, Myrta S, Wongchenko MJ, Lin E, Long JE, Foreman O, Junttila MR, et al.\n\n\nâ–¸ Subtype Discovery: Consensus nonnegative matrix factorization (NMF) across &gt;800 patients (TCGA + clinical trials)\nâ–¸ Classifier Development: PAM (Prediction Analysis for Microarrays) - 113-gene signature with 87-91% cross-cohort validation\nâ–¸ Multi-Cohort Integration: TCGA, OAK trial (Phase III), POPLAR, gp28363 trials; harmonization of batch effects\nâ–¸ Gene Set Enrichment: Camera method (limma) + MSigDB Hallmark collection\nâ–¸ Drug Response Modeling: Spearman correlations (subtype score vs 526 compounds, 89 cell lines), ANOVA for predictive modeling\nâ–¸ Survival Analysis: survfit, Cox proportional hazards models, interaction terms (STK11 Ã— subtype)\nâ–¸ Preclinical Models: 175 cell lines, 232 PDX, 108 GEMM tumors analyzed for subtype concordance\nâ–¸ Visualization: Heatmaps (z-scored, saturated Â±1.5), Kaplan-Meier curves, bar graphs, volcano plots\nKey Findings: Identified 3 subtypes (MUC, PRO, MES) with differential MEK inhibitor response; MES tumors benefit most from cobimetinib\nCode: GitHub Repository\n\n\n\n\n\nJournal: EMBO Molecular Medicine (2013) | DOI: 10.1002/emmm.201303123\nAuthors: Syed YA, Baer A, Hofer MP, GonzÃ¡lez GA, Rundle J, Myrta S, et al.\n\n\nâ–¸ Microarray Analysis: Rat Exon 1.0ST array (Affymetrix), RMA normalization, limma (moderated t-test), FDR correction (Storey & Tibshirani)\nâ–¸ Differential Expression: OPC differentiation timecourse (0h, 4h, 12h); identified Mapk pathway regulation\nâ–¸ qRT-PCR Validation: TaqMan assays, normalization to Î²2-microglobulin\nâ–¸ Western Blot Quantification: Densitometry (ROD) for p-Erk1/2, p-p38Mapk, p-Creb1\nâ–¸ Statistical Analysis: GraphPad Prism (ANOVA + Dunnettâ€™s, Mann-Whitney U, t-tests)\nKey Findings: PDE4 inhibition (rolipram) accelerates OPC differentiation and remyelination via cAMP-Mapk-Creb1 signaling\nData: GEO: GSE50042"
  },
  {
    "objectID": "publications.html#peer-reviewed-publications",
    "href": "publications.html#peer-reviewed-publications",
    "title": "Publications",
    "section": "",
    "text": "As bioinformatics co-author contributing computational analysis expertise\n\n\n\nJournal: iScience (2025) | DOI: 10.1016/j.isci.2025.113842\nAuthors: Kaufmann U, Wang J, Callow M, Fortin J, Myrta S, Nickles D, et al.\n\n\nâ–¸ CRISPR Screen Analysis: Processed ~160,000 sgRNAs using crisprVerse (screenCounter), TMM normalization on non-essential genes, limma-voom with robust empirical Bayes\nâ–¸ RNA-seq (Bulk): HTSeqGenie pipeline, GSNAP alignment (GRCh38), differential expression (edgeR, voom/limma), pathway enrichment (MSigDB Hallmark)\nâ–¸ ChIP-seq Integration: Public data analysis (GEO: GSE102616), BWA alignment, promoter enrichment (ZFX binding sites in 4 cancer cell lines)\nâ–¸ Clinical Data Analysis: TCGA integration, Cox proportional hazards models for survival, correlation analysis (ZFX expression vs patient outcomes)\nâ–¸ Visualization: Volcano plots, heatmaps, Kaplan-Meier curves, scatter plots\nKey Findings: Identified ZFX as biomarker for immunotherapy response; ZFX regulates apoptosis pathway genes including CASP3\nData: GEO accessions GSE276964 (in vitro), GSE276965 (in vivo)\n\n\n\n\n\nJournal: Cancer Immunology Research (2024) | DOI: 10.1158/2326-6066.CIR-23-0800\nAuthors: Besla R, Penuel E, Rosario GD, Cosino E, Myrta S, Polson AG, et al.\n\n\nâ–¸ RNA-seq (Sorted NK Cells): Smart-Seq V4 library prep (2ng input), HTSeqGenie processing, edgeR (logCPM), voom/limma differential expression (baseline vs 24h TDB)\nâ–¸ Gene Set Enrichment: fgsea with MSigDB collections (c2, c5, c7), pathway visualization (IFN, TNF, interleukin pathways)\nâ–¸ Cytokine Analysis: Luminex multiplex data integration (Human CD8+ T-cell 17+plex panel)\nâ–¸ Flow Cytometry Data: FlowJo analysis support, gating strategy optimization\nâ–¸ Visualization: Heat maps, bar graphs with multiple comparisons, pathway network diagrams\nKey Findings: TDB treatment activates NK cells via IL2/IL10 axis; enhanced ADCC observed in vitro and in vivo\nData: EGA accession EGAS00001006914\n\n\n\n\n\nJournal: bioRxiv (2023) | DOI: 10.1101/2023.07.24.550274\nAuthors: Laing S, Kruspig B, Shaw R, Officer-Jones L, Edwards S, McKinven D, Myrta S, et al.\n\n\nâ–¸ Bulk RNA-seq: Multiple timepoints (8w, 12w, endpoint), Metacore GeneGO pathway analysis, differential expression\nâ–¸ Single-Cell RNA-seq: 10X Genomics Chromium (40,000 cells/sample), 22 clusters identified using ImmGen databrowser, PANTHER overrepresentation analysis\nâ–¸ Pathway Enrichment: EGFR/ERBB signaling (33.5x enrichment, FDR 1.06e-2), immune evasion pathways\nâ–¸ Whole Exome Sequencing: COSMIC signature analysis (APOBEC mutagenesis signatures)\nâ–¸ Visualization: UMAPs, violin plots, correlation plots (AREG vs p-ERBB2), heatmaps\nKey Findings: ERBB ligand upregulation (AREG, HBEGF) mediates immune escape post-Î±PD-1 treatment; Afatinib restores immune infiltration\n\n\n\n\n\nJournal: Clinical Cancer Research (2021) | DOI: 10.1158/1078-0432.CCR-20-1835\nAuthors: Daemen A, Cooper JE, Myrta S, Wongchenko MJ, Lin E, Long JE, Foreman O, Junttila MR, et al.\n\n\nâ–¸ Subtype Discovery: Consensus nonnegative matrix factorization (NMF) across &gt;800 patients (TCGA + clinical trials)\nâ–¸ Classifier Development: PAM (Prediction Analysis for Microarrays) - 113-gene signature with 87-91% cross-cohort validation\nâ–¸ Multi-Cohort Integration: TCGA, OAK trial (Phase III), POPLAR, gp28363 trials; harmonization of batch effects\nâ–¸ Gene Set Enrichment: Camera method (limma) + MSigDB Hallmark collection\nâ–¸ Drug Response Modeling: Spearman correlations (subtype score vs 526 compounds, 89 cell lines), ANOVA for predictive modeling\nâ–¸ Survival Analysis: survfit, Cox proportional hazards models, interaction terms (STK11 Ã— subtype)\nâ–¸ Preclinical Models: 175 cell lines, 232 PDX, 108 GEMM tumors analyzed for subtype concordance\nâ–¸ Visualization: Heatmaps (z-scored, saturated Â±1.5), Kaplan-Meier curves, bar graphs, volcano plots\nKey Findings: Identified 3 subtypes (MUC, PRO, MES) with differential MEK inhibitor response; MES tumors benefit most from cobimetinib\nCode: GitHub Repository\n\n\n\n\n\nJournal: EMBO Molecular Medicine (2013) | DOI: 10.1002/emmm.201303123\nAuthors: Syed YA, Baer A, Hofer MP, GonzÃ¡lez GA, Rundle J, Myrta S, et al.\n\n\nâ–¸ Microarray Analysis: Rat Exon 1.0ST array (Affymetrix), RMA normalization, limma (moderated t-test), FDR correction (Storey & Tibshirani)\nâ–¸ Differential Expression: OPC differentiation timecourse (0h, 4h, 12h); identified Mapk pathway regulation\nâ–¸ qRT-PCR Validation: TaqMan assays, normalization to Î²2-microglobulin\nâ–¸ Western Blot Quantification: Densitometry (ROD) for p-Erk1/2, p-p38Mapk, p-Creb1\nâ–¸ Statistical Analysis: GraphPad Prism (ANOVA + Dunnettâ€™s, Mann-Whitney U, t-tests)\nKey Findings: PDE4 inhibition (rolipram) accelerates OPC differentiation and remyelination via cAMP-Mapk-Creb1 signaling\nData: GEO: GSE50042"
  },
  {
    "objectID": "publications.html#conference-abstracts",
    "href": "publications.html#conference-abstracts",
    "title": "Publications",
    "section": "ğŸ“„ Conference Abstracts",
    "text": "ğŸ“„ Conference Abstracts\n\nTranscriptional heterogeneity in lung adenocarcinoma reveals distinct therapeutic vulnerabilities\nConference: AACR Annual Meeting 2020\nPublication: Cancer Research (2020) | Abstract PO-101\nAuthors: Daemen A, Cooper JE, Myrta S, Wongchenko MJ, et al.\nPreliminary data presentation of LUAD subtyping project (later published in Clinical Cancer Research 2021)"
  },
  {
    "objectID": "publications.html#research-metrics",
    "href": "publications.html#research-metrics",
    "title": "Publications",
    "section": "ğŸ”¬ Research Metrics",
    "text": "ğŸ”¬ Research Metrics\n\n\n6 Publications\nPeer-reviewed journals\n\n\n3 Top-Tier Journals\nImpact Factor &gt;10\n\n\n&gt;800 Patients\nAnalyzed across studies\n\n\n5 Public Datasets\nGEO/EGA depositions"
  },
  {
    "objectID": "publications.html#expertise-demonstrated",
    "href": "publications.html#expertise-demonstrated",
    "title": "Publications",
    "section": "ğŸ¯ Expertise Demonstrated",
    "text": "ğŸ¯ Expertise Demonstrated\n\n\nRNA-seq Analysis\nâœ“ Bulk RNA-seq (HTSeqGenie, GSNAP, edgeR, DESeq2, limma-voom)\nâœ“ Single-cell RNA-seq (10X Genomics, Seurat-equivalent, UMAP, clustering)\nâœ“ Smart-Seq V4 ultra-low input (2ng â†’ 150pg cDNA â†’ Nextera XT)\n\n\nGenomic Screens\nâœ“ CRISPR screens (~160K sgRNAs, crisprVerse, TMM normalization)\nâœ“ ORF overexpression screens\nâœ“ Drug response screens (526 compounds, correlation modeling)\n\n\nMulti-Omics Integration\nâœ“ RNA-seq + WGS/WES + clinical data (TCGA, cBioPortal)\nâœ“ RNA-seq + ChIP-seq (promoter binding analysis)\nâœ“ RNA-seq + flow cytometry (immune profiling)\nâœ“ Spatial transcriptomics integration\n\n\nMachine Learning\nâœ“ Unsupervised: Consensus NMF (subtype discovery)\nâœ“ Supervised: PAM classifier (113-gene signature, 87-91% accuracy)\nâœ“ Feature engineering for drug response prediction\nâœ“ Cross-validation design (4-fold larger validation cohort)\n\n\nStatistical Rigor\nâœ“ Survival analysis (Cox models, Kaplan-Meier, log-rank tests)\nâœ“ Multiple testing correction (FDR, Benjamini-Hochberg, q-values)\nâœ“ Robust methods (empirical Bayes, moderated statistics)\nâœ“ Interaction modeling (gene Ã— treatment, STK11 Ã— subtype)\n\n\nReproducible Research\nâœ“ Public data deposition (GEO: 3 datasets, EGA: 1 dataset)\nâœ“ Code sharing (GitHub: LUAD.subtypes repository)\nâœ“ Methods transparency (detailed Materials & Methods sections)\nâœ“ FAIR data principles (metadata, accessibility)"
  },
  {
    "objectID": "publications.html#full-publication-list",
    "href": "publications.html#full-publication-list",
    "title": "Publications",
    "section": "ğŸ“– Full Publication List",
    "text": "ğŸ“– Full Publication List\n\n\n\n\nORCID\n\n\nView complete publication history and citation metrics"
  },
  {
    "objectID": "publications.html#interested-in-similar-analysis",
    "href": "publications.html#interested-in-similar-analysis",
    "title": "Publications",
    "section": "ğŸ’¼ Interested in Similar Analysis?",
    "text": "ğŸ’¼ Interested in Similar Analysis?\nI can apply these same methodologies to your projects:\n\nâ–¸ ğŸ§¬ NGS analysis (RNA-seq, scRNA-seq, ChIP-seq, CRISPR screens)\nâ–¸ ğŸ¤– Machine learning classifier development\nâ–¸ ğŸ“Š Multi-omics data integration\nâ–¸ ğŸ¥ Clinical trial biomarker discovery\nâ–¸ ğŸ“ˆ Interactive visualization & reporting\n\n\nğŸ“§Â Contact Me ğŸ’¼Â View Portfolio"
  },
  {
    "objectID": "index.html#bioinformatics-expert-9-years-ngs-ai-workflows",
    "href": "index.html#bioinformatics-expert-9-years-ngs-ai-workflows",
    "title": "Szymon Myrta | Bioinformatics Expert",
    "section": "Bioinformatics Expert | 9+ Years | NGS & AI Workflows",
    "text": "Bioinformatics Expert | 9+ Years | NGS & AI Workflows\nTransform your genomic data into actionable insights with reproducible pipelines and cutting-edge analysis.\n\nâš¡ Powered by the ACTN3 â€œSpeed Geneâ€ Philosophy - Fast, Efficient, High-Performance Bioinformatics\n\n\n\n9+\nYears Experience\n\n\n500+\nNGS Datasets Analyzed\n\n\n6\nPublications\n\n\n\nğŸ’¼Â Hire Me ğŸ“‚Â View Portfolio"
  },
  {
    "objectID": "index.html#what-problems-do-i-solve",
    "href": "index.html#what-problems-do-i-solve",
    "title": "Szymon Myrta | Bioinformatics Expert",
    "section": "ğŸ’¡ What Problems Do I Solve?",
    "text": "ğŸ’¡ What Problems Do I Solve?\n\n\nğŸ§¬ Raw NGS Data Chaos\nProblem: You have TBs of FASTQ files but no pipeline\nSolution: End-to-end analysis from QC â†’ DE â†’ figures\nTools: Snakemake, Seurat, edgeR, HTSeqGenie\n\n\nğŸ¤– AI-Ready Genomic Data\nProblem: Messy datasets, batch effects, imbalanced classes\nSolution: Harmonized, ML-ready perturbation datasets\nTools: CRISPR normalization, feature engineering, CV design\n\n\nğŸ“Š Publication-Quality Figures\nProblem: Analysis done but figures look unprofessional\nSolution: Heatmaps, UMAPs, survival curves ready for Nature/Cell\nTools: ggplot2, ComplexHeatmap, Quarto reports\n\n\nğŸ¥ Clinical Trial Biomarkers\nProblem: Which patients respond to your drug?\nSolution: Cox models, patient stratification, companion diagnostics\nTools: TCGA integration, survfit, pathway enrichment"
  },
  {
    "objectID": "index.html#core-services",
    "href": "index.html#core-services",
    "title": "Szymon Myrta | Bioinformatics Expert",
    "section": "ğŸ› ï¸ Core Services",
    "text": "ğŸ› ï¸ Core Services\n\n\n\nğŸ§¬\n\n\nNGS Analysis\nâ–¸ RNA-seq (bulk & single-cell)\nâ–¸ ChIP-seq, ATAC-seq, CUT&RUN\nâ–¸ WGS/WES variant calling\nâ–¸ scTCR/scBCR-seq repertoires\nâ–¸ CRISPR/ORF screen analysis\nâ–¸ Spatial transcriptomics (10X Visium)\nâ–¸ Long-read sequencing (PacBio, Nanopore)\nâ–¸ Methylation arrays, WGBS\nFormat: Quarto reports + GitHub repo\n\n\n\n\nâš™ï¸\n\n\nPipeline Development\nâ–¸ Snakemake/Nextflow workflows\nâ–¸ Docker containerization\nâ–¸ HPC optimization\nâ–¸ CI/CD integration\nâ–¸ Custom R packages\nFormat: Reproducible code + documentation\n\n\n\n\nğŸ¤–\n\n\nAI-Powered Analysis\nâ–¸ ML-ready feature extraction\nâ–¸ Predictive modeling (drug response)\nâ–¸ Multi-omics integration\nâ–¸ LLM-assisted code generation\nâ–¸ Automated QC systems\nFormat: Trained models + deployment scripts\n\n\n\n\nğŸ“ˆ\n\n\nInteractive Dashboards\nâ–¸ Shiny apps for data exploration\nâ–¸ Real-time QC monitoring\nâ–¸ Client-facing visualizations\nâ–¸ GitHub Pages portfolios\nâ–¸ Quarto knowledge bases\nFormat: Hosted app + source code\n\n\n\n\nğŸ”¬\n\n\nMulti-Omics Integration\nâ–¸ Transcriptomics + genomics + epigenomics\nâ–¸ Spatial transcriptomics analysis\nâ–¸ TCGA/GEO public data mining\nâ–¸ Cross-species comparisons\nâ–¸ Pathway enrichment analysis\nFormat: Integrated dataset + insights report\n\n\n\n\nğŸ¥\n\n\nClinical Trial Support\nâ–¸ Biomarker discovery & validation\nâ–¸ Patient stratification algorithms\nâ–¸ Survival analysis (Cox models)\nâ–¸ Companion diagnostic development\nâ–¸ Regulatory-compliant documentation\nFormat: Clinical-grade reports + code\n\n\n\n\nğŸ“§Â Discuss Your Project"
  },
  {
    "objectID": "index.html#technical-arsenal",
    "href": "index.html#technical-arsenal",
    "title": "Szymon Myrta | Bioinformatics Expert",
    "section": "ğŸ¯ Technical Arsenal",
    "text": "ğŸ¯ Technical Arsenal\n\n\nğŸ§¬ Bioinformatics\n   \nCore: limma, edgeR, DESeq2, fgsea, ComplexHeatmap\nSingle-cell: Seurat, UMAPs, cell type annotation\nCRISPR: crisprVerse, screenCounter, MAGeCK\nML: caret, PAM, consensus NMF, feature engineering\n\n\nâš™ï¸ Engineering\n   \nPipelines: Snakemake, Nextflow, Bash scripting\nReproducibility: Quarto, Shiny, RMarkdown, literate programming\nCompute: HPC clusters, parallel processing, CI/CD\nData: FASTQ/BAM/VCF parsing, dplyr, data.table\n\n\nğŸ“Š Visualization\n  \nStatic: ggplot2, ComplexHeatmap, volcano plots\nInteractive: Shiny dashboards, plotly, custom widgets\nReports: Quarto websites, dynamic RMarkdown, GitHub Pages\n\n\nğŸ—„ï¸ Data Sources\n  \nPublic: TCGA, GEO, EGA, SRA, cBioPortal\nClinical: OAK/POPLAR trials, FoundationOne\nPlatforms: Illumina (HiSeq, NovaSeq), 10X Genomics, PacBio"
  },
  {
    "objectID": "index.html#research-impact",
    "href": "index.html#research-impact",
    "title": "Szymon Myrta | Bioinformatics Expert",
    "section": "ğŸ“š Research Impact",
    "text": "ğŸ“š Research Impact\n\n\n6\nPublications in Top-Tier Journals\n\n\n800+\nPatient Samples Analyzed\n\n\n160K\nsgRNAs in CRISPR Screens\n\n\n\nFeatured Publications\n\nğŸ§¬ Transcription factor Zfx regulates tumor immune evasion\niScience (2025)\nRole: CRISPR screen analysis (160K sgRNAs), ChIP-seq, TCGA survival models\nğŸ“„Â Read Paper\n\n\nğŸ§¬ Transcriptional subtypes in lung adenocarcinoma\nClinical Cancer Research (2021)\nRole: NMF subtype discovery, 113-gene PAM classifier (87-91% accuracy)\nğŸ“„Â Read Paper | ğŸ’»Â Code\n\n\nğŸ§¬ ERBB signalling in KRAS-driven lung cancer\nbioRxiv (2023)\nRole: scRNA-seq analysis (10X, 22 clusters), PANTHER enrichment\nğŸ“„Â Read Paper\n\nğŸ“–Â View All Publications"
  },
  {
    "objectID": "index.html#ready-to-transform-your-genomic-data",
    "href": "index.html#ready-to-transform-your-genomic-data",
    "title": "Szymon Myrta | Bioinformatics Expert",
    "section": "Ready to Transform Your Genomic Data?",
    "text": "Ready to Transform Your Genomic Data?\nLetâ€™s discuss how I can accelerate your discoveries\n\nğŸ“§Â Email Me ğŸ’¼Â LinkedIn ğŸ¢Â ACTN3 Bioinformatics"
  },
  {
    "objectID": "about.html",
    "href": "about.html",
    "title": "About",
    "section": "",
    "text": "Szymon Myrta\n\n\nBioinformatics Expert | 9+ Years | Founder of ACTN3 Bioinformatics\nI transform complex genomic data into actionable insights through reproducible pipelines,\ncutting-edge analysis, and AI-powered workflows.\n\nâš¡ Named after the ACTN3 â€œSpeed Geneâ€ - symbolizing fast, efficient, high-performance bioinformatics"
  },
  {
    "objectID": "about.html#hi-im-szymon",
    "href": "about.html#hi-im-szymon",
    "title": "About",
    "section": "",
    "text": "Szymon Myrta\n\n\nBioinformatics Expert | 9+ Years | Founder of ACTN3 Bioinformatics\nI transform complex genomic data into actionable insights through reproducible pipelines,\ncutting-edge analysis, and AI-powered workflows.\n\nâš¡ Named after the ACTN3 â€œSpeed Geneâ€ - symbolizing fast, efficient, high-performance bioinformatics"
  },
  {
    "objectID": "about.html#professional-journey",
    "href": "about.html#professional-journey",
    "title": "About",
    "section": "ğŸ’¼ Professional Journey",
    "text": "ğŸ’¼ Professional Journey\n\nğŸ”¬ Bioinformatician | Roche (via Avenga)\nMay 2017 - Present | Remote\nLeading bioinformatics analysis for oncology and immunology research projects at one of the worldâ€™s largest pharmaceutical companies.\nKey Achievements:\nâ–¸ Co-authored 6 publications in top-tier journals (iScience, Clinical Cancer Research, Cancer Immunology Research, EMBO Molecular Medicine)\nâ–¸ Analyzed &gt;800 patient samples across multiple clinical trials (OAK, POPLAR, gp28363)\nâ–¸ Processed ~160,000 sgRNAs in genome-wide CRISPR screens\nâ–¸ Developed 113-gene classifier with 87-91% cross-cohort validation\nâ–¸ Built ML-ready datasets from scRNA-seq CRISPR perturbation screens\nTechnical Focus:\nâ–¸ NGS analysis (RNA-seq, scRNA-seq, ChIP-seq, scTCR/scBCR-seq, WGS/WES)\nâ–¸ CRISPR/ORF screen analysis\nâ–¸ Machine learning & predictive modeling\nâ–¸ Multi-omics data integration (TCGA, GEO, clinical trials)\nâ–¸ Pipeline development (Snakemake, Docker, HPC)\n\n\n\nğŸ’» LIMS Developer & Bioinformatician | Ardigen\nSeptember 2015 - April 2017 | KrakÃ³w, Poland\nâ–¸ Designed & maintained LIMS software (StarLIMS, JScript.NET, T-SQL)\nâ–¸ Developed R package supporting drug discovery workflows\nâ–¸ Integrated bioinformatics tools with laboratory information systems\n\n\n\nğŸ§ª LIMS Developer & ISO Coordinator | Selvita\nAugust 2014 - August 2015 | KrakÃ³w, Poland\nâ–¸ Led StarLIMS implementation in collaboration with Abbott\nâ–¸ Coordinated QA for ISO compliance during system deployment\nâ–¸ Bridge between IT, lab operations, and quality assurance\n\n\n\nğŸ“ Visiting Student | University of Cambridge\nMay 2013 - September 2013 | Anne McLaren Laboratory\nProject: Computational analysis of long non-coding RNAs during neural differentiation\nSupervisor: Dr.Â Mark Kotter\nMethods: R-based microarray analysis in stem cell biology"
  },
  {
    "objectID": "about.html#technical-skills",
    "href": "about.html#technical-skills",
    "title": "About",
    "section": "ğŸ› ï¸ Technical Skills",
    "text": "ğŸ› ï¸ Technical Skills\n\nCore Bioinformatics\nNGS Technologies:\nâœ“ RNA-seq: limma-voom, edgeR, DESeq2, HTSeqGenie, GSNAP\nâœ“ scRNA-seq: Seurat, Scanpy, UMAP, cell type annotation\nâœ“ CRISPR screens: crisprVerse, MAGeCK, TMM normalization\nâœ“ ChIP-seq, ATAC-seq, CUT&RUN: peak calling, motif enrichment\nâœ“ scTCR/scBCR-seq: immune repertoire profiling\nâœ“ WGS/WES: GATK, variant calling, COSMIC signatures\nâœ“ Spatial transcriptomics: 10X Visium analysis\nâœ“ Long-read sequencing: PacBio, Nanopore\nâœ“ Methylation: WGBS, Infinium arrays\nAnalysis Methods:\nâœ“ Pathway analysis: fgsea, MSigDB, IPA, Metacore GeneGO\nâœ“ Differential expression: limma, edgeR, DESeq2\nâœ“ Functional genomics: CRISPR/ORF screen hit calling\n\n\nMachine Learning & Statistics\nUnsupervised:\nâœ“ Consensus NMF, hierarchical clustering, PCA/UMAP\nSupervised:\nâœ“ PAM, caret, feature engineering, cross-validation design\nClinical:\nâœ“ Survival analysis: Cox models, Kaplan-Meier, survfit\nâœ“ Statistical tests: ANOVA, t-tests, Mann-Whitney U, FDR correction\n\n\nEngineering & Automation\nWorkflow Development:\nâœ“ Snakemake, Nextflow, Bash scripting\nReproducibility:\nâœ“ RMarkdown, Quarto, literate programming\nInfrastructure:\nâœ“ Version control: Git, GitHub/GitLab, CI/CD\nâœ“ Compute: HPC clusters, Docker, parallel processing\nâœ“ Data wrangling: dplyr, data.table, FASTQ/BAM/VCF parsing\n\n\nVisualization & Reporting\nStatic Graphics:\nâœ“ ggplot2, ComplexHeatmap, volcano plots, survival curves\nInteractive:\nâœ“ Shiny apps, plotly, custom dashboards\nDocumentation:\nâœ“ Quarto websites, dynamic RMarkdown, GitHub Pages\n\n\nData Sources & Integration\nPublic Databases:\nâœ“ TCGA, GEO, EGA, SRA, cBioPortal, FoundationOne\nClinical Data:\nâœ“ OAK/POPLAR trials, patient stratification\nPlatforms:\nâœ“ Illumina (HiSeq/NovaSeq), 10X Genomics, PacBio, Affymetrix"
  },
  {
    "objectID": "about.html#languages",
    "href": "about.html#languages",
    "title": "About",
    "section": "ğŸŒ Languages",
    "text": "ğŸŒ Languages\nâ–¸ ğŸ‡¬ğŸ‡§ English: Fluent - Scientific communication, publications, international teams\nâ–¸ ğŸ‡µğŸ‡± Polish: Native"
  },
  {
    "objectID": "about.html#what-drives-me",
    "href": "about.html#what-drives-me",
    "title": "About",
    "section": "ğŸ’¡ What Drives Me",
    "text": "ğŸ’¡ What Drives Me\n\n\nğŸš€ Professional Interests (2025 & Beyond)\nâ–¸ ğŸ¤– AI in Bioinformatics: LLM-assisted analysis, automated QC, AI-powered variant calling\nâ–¸ ğŸ§¬ Multi-Modal Omics: Spatial transcriptomics, single-cell + proteomics + epigenomics integration\nâ–¸ ğŸ§ª Non-coding RNA: lncRNA, miRNA, circRNA in cancer & development\nâ–¸ âš™ï¸ Workflow Engineering: Positron IDE + Quarto, Nextflow DSL2, cloud-native pipelines\nâ–¸ ğŸ¯ CRISPR & Functional Genomics: Perturb-seq, base/prime editor screens, transcriptome engineering\nâ–¸ ğŸ¥ Precision Medicine: Real-time clinical decision support, pharmacogenomics, liquid biopsy\n\n\nğŸƒ Personal Passions\nâ–¸ ğŸ“š Continuous learning & skill development\nâ–¸ ğŸƒ Licensed athletics referee\nâ–¸ ğŸ’ª Healthy lifestyle & professional athletics training\nâ–¸ ğŸ§˜ Work-life balance advocacy"
  },
  {
    "objectID": "about.html#lets-work-together",
    "href": "about.html#lets-work-together",
    "title": "About",
    "section": "ğŸ¤ Letâ€™s Work Together",
    "text": "ğŸ¤ Letâ€™s Work Together\n\nIâ€™m passionate about turning complex genomic data into discoveries that matter.\nWhether youâ€™re a biotech startup, academic lab, pharma company, or CRO, letâ€™s discuss how I can help accelerate your research with cutting-edge bioinformatics solutions.\nConnect with me:\nğŸ“§Â Email ğŸ’¼Â LinkedIn ğŸ“‹Â ORCID"
  },
  {
    "objectID": "contact.html",
    "href": "contact.html",
    "title": "Contact",
    "section": "",
    "text": "Iâ€™m available for contract projects, consulting, and long-term collaborations\nin bioinformatics, genomics, and AI-powered data analysis.\nTypical Response Time: Within 24 hours"
  },
  {
    "objectID": "contact.html#lets-collaborate",
    "href": "contact.html#lets-collaborate",
    "title": "Contact",
    "section": "",
    "text": "Iâ€™m available for contract projects, consulting, and long-term collaborations\nin bioinformatics, genomics, and AI-powered data analysis.\nTypical Response Time: Within 24 hours"
  },
  {
    "objectID": "contact.html#get-in-touch",
    "href": "contact.html#get-in-touch",
    "title": "Contact",
    "section": "ğŸ’¼ Get in Touch",
    "text": "ğŸ’¼ Get in Touch\n\n\nğŸ“§ Email\nPersonal: szymon.myrta@gmail.com\nCompany: kontakt@actn3.pl\nBest for: Detailed project inquiries, proposals\n\n\nğŸ’¼ LinkedIn\nlinkedin.com/in/myrta/\nBest for: Professional networking, quick messages\n\n\nğŸ¢ ACTN3 Bioinformatics\nWebsite: actn3.pl\nGitHub: ACTN3Bioinformatics\nBest for: Company info, project examples\n\n\nğŸ”¬ ORCID Profile\n0000-0003-1714-6105\nBest for: Publication history, citation metrics"
  },
  {
    "objectID": "contact.html#how-we-can-work-together",
    "href": "contact.html#how-we-can-work-together",
    "title": "Contact",
    "section": "ğŸ¤ How We Can Work Together",
    "text": "ğŸ¤ How We Can Work Together\n\n\nğŸ§¬ Contract Analysis Projects\nDuration: 2-20 weeks depending on scope\nExamples: RNA-seq analysis, scRNA-seq clustering, CRISPR screen hit identification\nğŸ“‹Â View Service Details\n\n\n\nâš™ï¸ Pipeline Development\nDuration: 4-12 weeks\nDeliverables: Snakemake/Nextflow workflows, Docker containers, documentation\nğŸ’»Â See Portfolio Examples\n\n\n\nğŸ¤– AI Integration & ML Modeling\nDuration: 6-16 weeks\nDeliverables: ML-ready datasets, trained models, deployment scripts\nğŸš€Â Learn More\n\n\n\nğŸ“Š Publication Support\nDuration: 2-6 weeks\nDeliverables: Methods sections, supplementary analyses, publication-quality figures\nğŸ“šÂ View My Publications\n\n\n\nğŸ“ Training & Workshops\nDuration: 1-3 days\nTopics: R/Bioconductor, reproducible workflows, NGS analysis best practices\nCustom workshops available upon request"
  },
  {
    "objectID": "contact.html#project-pricing",
    "href": "contact.html#project-pricing",
    "title": "Contact",
    "section": "ğŸ’° Project Pricing",
    "text": "ğŸ’° Project Pricing\n\nPricing varies based on project complexity, timeline, and deliverables.\nContact me for a custom quote tailored to your needs."
  },
  {
    "objectID": "contact.html#work-arrangements",
    "href": "contact.html#work-arrangements",
    "title": "Contact",
    "section": "ğŸŒ Work Arrangements",
    "text": "ğŸŒ Work Arrangements\n\nâœ… Fully Remote (9+ years experience)\nâœ… Flexible Hours (European time zones preferred)\nâœ… International Clients (US, UK, EU experience)\nâœ… English Fluent (C1/C2 scientific communication)\nâœ… Polish Native\nAvailability: Full-time contracts, part-time projects, hourly consulting"
  },
  {
    "objectID": "contact.html#frequently-asked-questions",
    "href": "contact.html#frequently-asked-questions",
    "title": "Contact",
    "section": "â“ Frequently Asked Questions",
    "text": "â“ Frequently Asked Questions\n\n\nWhat file formats do you work with?\nFASTQ, BAM, VCF, h5ad, Seurat objects, CSV/TSV, Excel, and most genomics formats.\n\n\nDo you sign NDAs?\nYes, Iâ€™m happy to sign NDAs for confidential projects.\n\n\nCan you work with proprietary data?\nAbsolutely. I have 9+ years experience with pharma/biotech confidential datasets.\n\n\nDo you provide publication support?\nYes! I can write Methods sections, create supplementary analyses, and prepare publication-quality figures.\n\n\nCan you train my team?\nYes, I offer custom workshops on R/Bioconductor, reproducible workflows, and NGS best practices.\n\n\nWhat is your typical project timeline?\nâ–¸ Small projects (RNA-seq analysis): 2-4 weeks\nâ–¸ Medium projects (scRNA-seq, pipelines): 4-8 weeks\nâ–¸ Large projects (multi-omics, ML): 8-16 weeks\n\n\nHow do you ensure reproducibility?\nAll analyses include version-controlled code (Git), containerization (Docker), detailed documentation (Quarto/RMarkdown), and comprehensive reports with session info."
  },
  {
    "objectID": "contact.html#ready-to-start",
    "href": "contact.html#ready-to-start",
    "title": "Contact",
    "section": "ğŸš€ Ready to Start?",
    "text": "ğŸš€ Ready to Start?\n\nLetâ€™s turn your genomic data into discoveries\nPrefer email? Write to szymon.myrta@gmail.com\nLinkedIn? Connect at linkedin.com/in/myrta/\nCompany inquiries? Contact kontakt@actn3.pl\nğŸ“§Â Email Me Now ğŸ’¼Â LinkedIn Message"
  },
  {
    "objectID": "portfolio.html",
    "href": "portfolio.html",
    "title": "Portfolio",
    "section": "",
    "text": "AI-Ready Perturbation Datasets\n\n\n\nSnakemake Workflow\n\n\nReproducible Snakemake pipeline producing harmonized, balanced, ML-ready perturbation datasets from single-cell CRISPR screens.\nKey Features:\nâ–¸ Automated QC + normalization (Seurat, sctransform)\nâ–¸ Balanced control/perturbation groups\nâ–¸ Docker containerization for reproducibility\nâ–¸ Integrated Quarto reports\nTech Stack: Snakemake, R/Seurat, Docker, Quarto\nğŸ”—Â GitHub Repository ğŸ“–Â Documentation\n\n\n\nKnowledge Base for Pharmaceutical Bioinformatics\n\n\n\nQuarto Website\n\n\nComprehensive Quarto website documenting R/Pharma 2025 workshops, tools, and modern R workflows for pharma/biotech.\nKey Features:\nâ–¸ Structured workshop documentation\nâ–¸ Reproducible examples (Positron IDE, Shiny)\nâ–¸ Curated resource library\nâ–¸ GitHub Pages deployment\nTech Stack: Quarto, RMarkdown, GitHub Actions, Positron\nğŸ”—Â GitHub Repository ğŸŒÂ Live Site"
  },
  {
    "objectID": "portfolio.html#featured-projects",
    "href": "portfolio.html#featured-projects",
    "title": "Portfolio",
    "section": "",
    "text": "AI-Ready Perturbation Datasets\n\n\n\nSnakemake Workflow\n\n\nReproducible Snakemake pipeline producing harmonized, balanced, ML-ready perturbation datasets from single-cell CRISPR screens.\nKey Features:\nâ–¸ Automated QC + normalization (Seurat, sctransform)\nâ–¸ Balanced control/perturbation groups\nâ–¸ Docker containerization for reproducibility\nâ–¸ Integrated Quarto reports\nTech Stack: Snakemake, R/Seurat, Docker, Quarto\nğŸ”—Â GitHub Repository ğŸ“–Â Documentation\n\n\n\nKnowledge Base for Pharmaceutical Bioinformatics\n\n\n\nQuarto Website\n\n\nComprehensive Quarto website documenting R/Pharma 2025 workshops, tools, and modern R workflows for pharma/biotech.\nKey Features:\nâ–¸ Structured workshop documentation\nâ–¸ Reproducible examples (Positron IDE, Shiny)\nâ–¸ Curated resource library\nâ–¸ GitHub Pages deployment\nTech Stack: Quarto, RMarkdown, GitHub Actions, Positron\nğŸ”—Â GitHub Repository ğŸŒÂ Live Site"
  },
  {
    "objectID": "portfolio.html#client-projects",
    "href": "portfolio.html#client-projects",
    "title": "Portfolio",
    "section": "ğŸ“Š Client Projects",
    "text": "ğŸ“Š Client Projects\n\n\nğŸ§¬ Lung Cancer Subtype Classifier\nPrecision Medicine Tool for MEK Inhibitor Response\nDeveloped 113-gene PAM classifier identifying 3 transcriptional subtypes (MUC, PRO, MES) in &gt;800 lung adenocarcinoma patients. Classifier predicts MEK inhibitor response with 87-91% accuracy.\nImpact: Published in Clinical Cancer Research (2021)\nMethods: Consensus NMF, PAM, survfit, Cox models\nTools: R/Bioconductor, TCGA/cBioPortal integration\nğŸ“„Â Publication\n\n\nğŸ”¬ CRISPR Screen Analysis Platform\nGenome-Wide Screen for Immunotherapy Resistance\nAnalyzed ~160,000 sgRNAs screening for tumor immune evasion genes. Identified ZFX transcription factor as biomarker for anti-PD-1 response.\nImpact: Published in iScience (2025)\nMethods: crisprVerse, TMM normalization, edgeR, ChIP-seq\nTools: R/Bioconductor, BWA, COSMIC signatures\nğŸ“„Â Publication\n\n\nğŸ§« Single-Cell Atlas of Tumor Microenvironment\nMulti-Modal Analysis of KRAS-Driven Lung Cancer\n10X Genomics scRNA-seq analysis (40,000 cells, 22 clusters) revealing EGFR/ERBB-mediated immune escape mechanisms.\nImpact: bioRxiv preprint (2023)\nMethods: ImmGen annotation, PANTHER enrichment, UMAPs\nTools: 10X Genomics, Seurat, WES integration\nğŸ“„Â Preprint\n\n\nğŸ’Š NK Cell Activation Profiling\nBispecific Antibody Mechanism Study\nRNA-seq analysis of NK cells post-TDB treatment, identifying cytokine-driven activation pathways (IFN, TNF, IL2/IL10 axes).\nImpact: Published in Cancer Immunology Research (2024)\nMethods: HTSeqGenie, fgsea, MSigDB enrichment, Luminex integration\nTools: R/Bioconductor, Smart-Seq V4, NovaSeq 6000\nğŸ“„Â Publication\n\n\nğŸ§  CNS Remyelination Biomarker Discovery\nMicroarray Analysis for Multiple Sclerosis Therapy\nIdentified PDE4 inhibition as therapeutic approach for remyelination. Analyzed microarray data (Rat Exon 1.0ST) with integrated in vivo validation.\nImpact: Published in EMBO Molecular Medicine (2013)\nMethods: RMA normalization, limma, qRT-PCR validation\nTools: Affymetrix platform, R/Bioconductor, GEO (GSE50042)\nğŸ“„Â Publication | ğŸ“ŠÂ Data\n\n\nğŸ“ˆ Interactive Shiny Dashboard Suite\nReal-Time NGS QC & Exploratory Analysis\nCustom Shiny applications for client-facing data exploration, including:\nâ–¸ Real-time sequencing QC monitoring\nâ–¸ Interactive UMAP/volcano plot explorers\nâ–¸ Drug response visualization tools\nâ–¸ Pathway enrichment browsers\nTech Stack: Shiny, ggplot2, plotly, DT, shinydashboard\nDeployment: RStudio Connect / shinyapps.io\nğŸ’»Â Demo Available Upon Request"
  },
  {
    "objectID": "portfolio.html#open-source-contributions",
    "href": "portfolio.html#open-source-contributions",
    "title": "Portfolio",
    "section": "ğŸ› ï¸ Open Source Contributions",
    "text": "ğŸ› ï¸ Open Source Contributions\n\n\nğŸ“¦ R Package Development\nFluidigm Data Handler\nCustom R package for Fluidigm qPCR data processing and analysis developed during Roche/Avenga tenure.\nFeatures: Automated QC, batch correction, visualization\nStatus: Internal use (proprietary)\n\n\nğŸ”§ Pipeline Templates\nSnakemake/Nextflow Starters\nOpen-source templates for common NGS workflows (RNA-seq, ChIP-seq, CRISPR screens) with Docker integration.\nStatus: In development for ACTN3 Bioinformatics\nğŸ”—Â Coming Soon\n\n\nğŸ“š Documentation & Tutorials\nR/Pharma Workshop Materials\nQuarto-based educational resources for pharmaceutical bioinformatics, including reproducible examples and best practices.\nğŸŒÂ View Portal"
  },
  {
    "objectID": "portfolio.html#want-to-collaborate",
    "href": "portfolio.html#want-to-collaborate",
    "title": "Portfolio",
    "section": "ğŸ’¼ Want to Collaborate?",
    "text": "ğŸ’¼ Want to Collaborate?\nIâ€™m available for:\nâ–¸ ğŸ§¬ Contract NGS Analysis\nâ–¸ âš™ï¸ Pipeline Development (custom Snakemake/Nextflow workflows)\nâ–¸ ğŸ¤– AI Integration (ML-ready dataset preparation, predictive modeling)\nâ–¸ ğŸ“Š Shiny Dashboard Creation (interactive data exploration tools)\nâ–¸ ğŸ“– Publication Support (methods sections, supplementary analyses, figures)\n\nğŸ“§Â Discuss Your Project ğŸ’¼Â View LinkedIn"
  }
]